An Approach for Increasing Brain Blood Flow and Oxygen Delivery

Date: August 7, 2025
Time: 2pm Eastern/11am Pacific
Location: Virtual (link provided upon registration)

Free Educational Webinar! Register Today and submit questions for our speakers.

About the Webinar

Cognitive dysfunction—often described as “brain fog”—is one of the most persistent and life-altering symptoms associated with Long COVID. Cognitive dysfunction and fatigue following COVID has been closely tied to reductions in blood flow to the brain, which deprives the brain of oxygen and nutrients. This webinar explores a novel approach to improving brain blood flow and oxygen delivery through the Hi-OxSR sequential rebreather and highlights how digital health platforms like unhide® can transform the way we track progress and evaluate health innovative technology.

Join us for a FREE educational discussion that will cover:
✔ The mechanisms behind COVID-related cognitive dysfunction
✔ The science of CO₂ and its role in regulating brain blood flow
✔ How the Hi-OxSR rebreather may help improve cognitive function
✔ How the unhide® platform enables real-time tracking of treatment impact through patient-reported data and wearable integrations

This is your chance to learn from experts at the intersection of respiratory therapy, neuroscience, and patient-driven research.

Who Should Attend?

Patients, caregivers, clinicians, researchers, and anyone interested in cutting-edge health innovations in post-viral care, brain health, and personalized monitoring.

Speakers

Christy Jagdfeld – CEO, Brain Inflammation Collaborative

Christy Jagdfeld, CPA, is a patient advocate and caregiver of individuals with neuroinflammatory disorders. She served as a volunteer, Treasurer, and leader at Dysautonomia International and PANDAS Network for a combined total of 15 years. She has organized fundraising events, patient seminars, and clinician conferences both in-person and virtual. She has overseen website and video content creation, staff hiring and development, accounting and business functions, policy creation, fundraising activities, networking and taken part in local speaking engagements. Seeing a need for research that provided a more systematic and collaborative approach to infection and inflammation driven chronic illnesses, she co-founded BIC.

Alex Stenzler – President, 12th Man Technologies, Inc.

Alex Stenzler is the president of 12th Man Technologies, Inc., an R&D corporation, and Chief Science Officer for Monitored Therapeutics, a telehealthcare company. His background is in pulmonary and critical care medicine and infectious diseases. As a non-physician, he has been working in the field of pulmonary function testing since 1968. He spent half of his career managing Respiratory Care Departments, COPD Clinics and Pulmonary Function Laboratories, or teaching pulmonary function technology as an Assistant Professor at the State University of New York at Stony Brook and twelve years at the Graduate School of Adelphi University. He has been the PI for two NIH and one DARPA (anti-viral) grant and has extensive research experience, including more than 30 years of research and development in the healthcare industry, having been the Vice President of Advanced Technologies for Cardinal Health’s Respiratory Group. More than twenty years ago he worked on technology to control cerebral blood flow as a diagnostic technique, which work he currently has transitioned for the treatment of long COVID. He has developed technology for protecting healthcare workers from viruses going back to the 2003 Canadian outbreak and has designed unique N95 masks for respiratory system protection. He has co-authored 24 peer-reviewed papers and one book chapter on pulmonary function testing.

Dr. Megan Fitzgerald – Principal Investigator, unhide®

Megan L. Fitzgerald PhD earned her doctorate in Neuroscience and Neurology from Weill Cornell Medical College, with a thesis focused on adolescent neuroanatomy and cannabinoid receptors. She completed postdoctoral work at Mt Sinai and secured an NIH fellowship at Columbia University. There, she investigated neuroanatomical links to suicide while pioneering stem cell studies. Dr. Fitzgerald earned the Young Investigator Award from NARSAD and from the American Foundation for Suicide Prevention (AFSP). She continued her research in regenerative medicine for brain and behavior disorders until March 2020, when she became ill with COVID-19. Like millions of Americans, Dr. Fitzgerald’s infection led to Long Covid—a debilitating condition without a cure that is characterized by fatigue, neurological symptoms, and post-exertional malaise, among many other symptoms.

Dr. Fitzgerald pivoted her research to study her own illness, learning from her first-hand experience of living with Long Covid about gaps in scientific and medical research as well as clinical care. She joined the Patient-Led Research Collaborative (PLRC) in late 2020 to leverage her scientific background to try to provide insights that would improve the lives and health of other patients. At PLRC, she developed and co-led a large-scale survey on the health impact of COVID-19 reinfections, helped to integrate a patient perspective into many clinical and basic research studies on Long Covid, and served in a leadership role. With the Brain Inflammation Collaborative, she aims to explore the connections between inflammation and the mood and neurological symptoms that patients experience, such as brain fog, and to continue to foster collaboration by bridging the gap between patients, clinicians, and scientists.

Tom Morse – Patient Perspective

Tom Morse is a retired IBM executive consultant who developed Long Covid in 2022 and suffered debilitating symptoms including heavy brain fog, balance issues, and migraines. He found improvement from the increased CO2 and improved blood brain flow.